Dr. Megan McLaughlin has been selected to receive the 2025 Dr. Nanette K. Wenger Research Goes Red Award for her study published in the American Heart Association's journal Hypertension. Her research, which analyzed data from over 47,000 postpartum individuals, identified critical gaps in care following hypertensive disorders of pregnancy, a major risk factor for future cardiovascular disease. The study found that while most patients attended a postpartum visit, attendance varied significantly by race, ethnicity, insurance status, and socioeconomic factors, revealing systemic inequities in healthcare access.
Furthermore, the research documented that many patients did not receive essential counseling or screening for cardiovascular risk factors during these visits. This included a lack of lifestyle guidance, smoking cessation support, and diabetes testing. These findings represent missed opportunities to intervene early and improve long-term heart health outcomes. Stacey E. Rosen, the American Heart Association's volunteer president, emphasized the importance of this work, stating it underscores the critical role of early education and targeted intervention in preventing long-term heart disease, particularly among high-risk populations.
The award, named for pioneering cardiologist Dr. Nanette K. Wenger, recognizes the best research article on cardiovascular disease and stroke in women published in the Association's journals. Dr. McLaughlin's manuscript was selected from 123 international submissions evaluated for scientific impact, innovation, and methodology. Her work aligns with the broader goals of the American Heart Association's Research Goes Red initiative, which aims to empower women to contribute to health research.
The implications of this research are substantial for clinical practice and public health policy. By quantifying disparities in postpartum care and identifying specific areas where counseling and screening are lacking, the study provides a clear roadmap for improving care standards. It highlights the need for standardized, equitable postpartum protocols that actively address cardiovascular risk in women who have experienced hypertensive disorders of pregnancy. This targeted approach is crucial for mitigating the elevated long-term risk of heart disease in this group. The findings offer evidence that could inform future clinical guidelines and interventions, ultimately aiming to reduce cardiovascular morbidity and mortality among women by ensuring they receive necessary support and monitoring during a critical window for preventive care.
